ProKidney Historical Financial Ratios

PROK Stock

USD 0.99 0.02 2.22%

ProKidney Corp is promptly reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0, Average Payables of 0.0, Stock Based Compensation To Revenue of 309 or Capex To Depreciation of 10.2 will help investors to properly organize and evaluate ProKidney Corp financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

About ProKidney Financial Ratios Analysis

ProKidney CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate ProKidney Corp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on ProKidney financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across ProKidney Corp history.

ProKidney Corp Financial Ratios Chart

At this time, ProKidney Corp's Capex Per Share is quite stable compared to the past year. Interest Debt Per Share is expected to rise to 0.02 this year, although the value of Free Cash Flow Yield will most likely fall to (0.62).

Price To Sales Ratio Days Sales Outstanding Book Value Per Share Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing ProKidney Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ProKidney Corp sales, a figure that is much harder to manipulate than other ProKidney Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from ProKidney Corp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into ProKidney Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.At this time, ProKidney Corp's Capex Per Share is quite stable compared to the past year. Interest Debt Per Share is expected to rise to 0.02 this year, although the value of Free Cash Flow Yield will most likely fall to (0.62).

	2022	2024	2025 (projected)
Net Debt To EBITDA	3.39	0.61	0.75
Intangibles To Total Assets	4.11E-4	4.73E-4	4.49E-4

Net Debt To E B I T D A Intangibles To Total Assets

ProKidney Corp fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Net Income Per Share	Payables Turnover	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield
Price To Sales Ratio		0.39	1.0	-0.19	0.5	0.49	-0.68	0.39	1.0	0.4	-0.43	-0.3	-0.34	-0.18	-0.46	0.87	0.72	-0.46	0.48	0.14	-0.57	-0.46	-0.22	-0.54	-0.46	0.53
Ptb Ratio	0.39		0.39	-0.56	0.53	0.56	-0.24	1.0	0.39	0.54	-0.92	0.41	-0.32	-0.56	-0.08	0.51	0.24	-0.08	0.28	0.5	-0.38	-0.08	-0.93	-0.28	-0.08	0.77
Days Sales Outstanding	1.0	0.39		-0.19	0.5	0.49	-0.68	0.39	1.0	0.4	-0.43	-0.3	-0.34	-0.18	-0.46	0.87	0.72	-0.46	0.48	0.14	-0.57	-0.46	-0.22	-0.54	-0.46	0.53
Book Value Per Share	-0.19	-0.56	-0.19		-0.69	-0.91	0.42	-0.56	-0.19	-0.9	0.7	-0.42	0.57	1.0	0.64	-0.43	-0.44	0.64	-0.43	-0.99	0.8	0.64	0.34	0.75	0.64	-0.9
Free Cash Flow Yield	0.5	0.53	0.5	-0.69		0.88	-0.89	0.53	0.5	0.92	-0.61	-0.25	-0.01	-0.67	-0.65	0.82	0.86	-0.65	-0.02	0.63	-0.79	-0.65	-0.29	-0.76	-0.65	0.79
Operating Cash Flow Per Share	0.49	0.56	0.49	-0.91	0.88		-0.73	0.56	0.49	0.98	-0.67	0.07	-0.45	-0.9	-0.81	0.73	0.75	-0.81	0.37	0.9	-0.95	-0.81	-0.27	-0.91	-0.81	0.92
Capex To Depreciation	-0.68	-0.24	-0.68	0.42	-0.89	-0.73		-0.24	-0.68	-0.75	0.35	0.57	-0.07	0.4	0.72	-0.91	-0.99	0.72	0.03	-0.39	0.76	0.72	0.0	0.77	0.72	-0.59
Pb Ratio	0.39	1.0	0.39	-0.56	0.53	0.56	-0.24		0.39	0.54	-0.92	0.41	-0.32	-0.56	-0.08	0.51	0.24	-0.08	0.28	0.5	-0.38	-0.08	-0.93	-0.28	-0.08	0.77
Ev To Sales	1.0	0.39	1.0	-0.19	0.5	0.49	-0.68	0.39		0.4	-0.43	-0.3	-0.34	-0.18	-0.46	0.87	0.72	-0.46	0.48	0.14	-0.57	-0.46	-0.22	-0.54	-0.46	0.53
Free Cash Flow Per Share	0.4	0.54	0.4	-0.9	0.92	0.98	-0.75	0.54	0.4		-0.64	0.02	-0.32	-0.89	-0.78	0.69	0.74	-0.78	0.24	0.88	-0.91	-0.78	-0.26	-0.88	-0.78	0.89
Roic	-0.43	-0.92	-0.43	0.7	-0.61	-0.67	0.35	-0.92	-0.43	-0.64		-0.47	0.41	0.69	0.14	-0.57	-0.34	0.14	-0.35	-0.61	0.45	0.14	0.87	0.35	0.14	-0.89
Net Income Per Share	-0.3	0.41	-0.3	-0.42	-0.25	0.07	0.57	0.41	-0.3	0.02	-0.47		-0.64	-0.45	0.28	-0.38	-0.55	0.28	0.52	0.4	0.1	0.28	-0.51	0.18	0.28	0.31
Payables Turnover	-0.34	-0.32	-0.34	0.57	-0.01	-0.45	-0.07	-0.32	-0.34	-0.32	0.41	-0.64		0.59	0.37	-0.12	-0.01	0.37	-0.97	-0.58	0.47	0.37	0.19	0.42	0.37	-0.53
Cash Per Share	-0.18	-0.56	-0.18	1.0	-0.67	-0.9	0.4	-0.56	-0.18	-0.89	0.69	-0.45	0.59		0.63	-0.41	-0.42	0.63	-0.45	-0.99	0.79	0.63	0.34	0.74	0.63	-0.89
Pocfratio	-0.46	-0.08	-0.46	0.64	-0.65	-0.81	0.72	-0.08	-0.46	-0.78	0.14	0.28	0.37	0.63		-0.6	-0.77	1.0	-0.33	-0.7	0.95	1.0	-0.28	0.98	1.0	-0.56
Interest Coverage	0.87	0.51	0.87	-0.43	0.82	0.73	-0.91	0.51	0.87	0.69	-0.57	-0.38	-0.12	-0.41	-0.6		0.93	-0.6	0.18	0.39	-0.74	-0.6	-0.29	-0.71	-0.6	0.71
Capex To Operating Cash Flow	0.72	0.24	0.72	-0.44	0.86	0.75	-0.99	0.24	0.72	0.74	-0.34	-0.55	-0.01	-0.42	-0.77	0.93		-0.77	0.04	0.43	-0.81	-0.77	0.03	-0.82	-0.77	0.6
Pfcf Ratio	-0.46	-0.08	-0.46	0.64	-0.65	-0.81	0.72	-0.08	-0.46	-0.78	0.14	0.28	0.37	0.63	1.0	-0.6	-0.77		-0.33	-0.7	0.95	1.0	-0.28	0.98	1.0	-0.55
Days Payables Outstanding	0.48	0.28	0.48	-0.43	-0.02	0.37	0.03	0.28	0.48	0.24	-0.35	0.52	-0.97	-0.45	-0.33	0.18	0.04	-0.33		0.42	-0.41	-0.33	-0.16	-0.37	-0.33	0.47
Income Quality	0.14	0.5	0.14	-0.99	0.63	0.9	-0.39	0.5	0.14	0.88	-0.61	0.4	-0.58	-0.99	-0.7	0.39	0.43	-0.7	0.42		-0.82	-0.7	-0.25	-0.78	-0.7	0.85
Roe	-0.57	-0.38	-0.57	0.8	-0.79	-0.95	0.76	-0.38	-0.57	-0.91	0.45	0.1	0.47	0.79	0.95	-0.74	-0.81	0.95	-0.41	-0.82		0.95	0.03	0.99	0.95	-0.79
Ev To Operating Cash Flow	-0.46	-0.08	-0.46	0.64	-0.65	-0.81	0.72	-0.08	-0.46	-0.78	0.14	0.28	0.37	0.63	1.0	-0.6	-0.77	1.0	-0.33	-0.7	0.95		-0.28	0.98	1.0	-0.56
Pe Ratio	-0.22	-0.93	-0.22	0.34	-0.29	-0.27	0.0	-0.93	-0.22	-0.26	0.87	-0.51	0.19	0.34	-0.28	-0.29	0.03	-0.28	-0.16	-0.25	0.03	-0.28		-0.08	-0.28	-0.57
Return On Tangible Assets	-0.54	-0.28	-0.54	0.75	-0.76	-0.91	0.77	-0.28	-0.54	-0.88	0.35	0.18	0.42	0.74	0.98	-0.71	-0.82	0.98	-0.37	-0.78	0.99	0.98	-0.08		0.98	-0.72
Ev To Free Cash Flow	-0.46	-0.08	-0.46	0.64	-0.65	-0.81	0.72	-0.08	-0.46	-0.78	0.14	0.28	0.37	0.63	1.0	-0.6	-0.77	1.0	-0.33	-0.7	0.95	1.0	-0.28	0.98		-0.56
Earnings Yield	0.53	0.77	0.53	-0.9	0.79	0.92	-0.59	0.77	0.53	0.89	-0.89	0.31	-0.53	-0.89	-0.56	0.71	0.6	-0.55	0.47	0.85	-0.79	-0.56	-0.57	-0.72	-0.56

Click cells to compare fundamentals

ProKidney Corp Account Relationship Matchups

ProKidney Corp fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Ptb Ratio	191.15	68.59	(0.38)	(0.0996)	(0.21)	(0.2)
Book Value Per Share	0.0529	0.14	8.21	6.34	3.18	2.42
Free Cash Flow Yield	(0.0162)	(0.0301)	(0.19)	(1.13)	(0.59)	(0.62)
Operating Cash Flow Per Share	(0.14)	(0.27)	(1.25)	(1.46)	(1.0)	(1.05)
Capex To Depreciation	5.66	2.62	0.61	10.79	9.71	10.2
Pb Ratio	191.15	68.59	(0.38)	(0.0996)	(0.21)	(0.2)
Free Cash Flow Per Share	(0.16)	(0.3)	(1.28)	(2.01)	(1.0)	(1.05)
Roic	(2.35)	(1.95)	(0.3)	(0.4)	(0.45)	(0.47)
Net Income Per Share	(0.14)	(0.3)	(2.41)	(0.57)	(0.48)	(0.51)
Cash Per Share	0.0245	0.11	7.97	5.88	2.84	2.27
Pocfratio	(74.88)	(36.71)	(5.48)	(1.22)	(1.69)	(1.77)
Capex To Operating Cash Flow	(0.22)	(0.1)	(0.0239)	(0.38)	(0.44)	(0.41)
Pfcf Ratio	(61.54)	(33.27)	(5.35)	(0.88)	(1.69)	(1.77)
Income Quality	0.94	0.91	0.52	0.66	0.77	0.88
Roe	(2.71)	(2.05)	0.14	0.0321	0.0615	0.0646
Ev To Operating Cash Flow	(74.76)	(36.33)	0.85	(0.6)	(0.92)	(0.97)
Pe Ratio	(70.49)	(33.48)	(2.85)	(3.1)	(3.48)	(3.66)
Return On Tangible Assets	(1.67)	(1.38)	(0.29)	(0.0843)	(0.14)	(0.15)
Ev To Free Cash Flow	(61.45)	(32.93)	0.83	(0.43)	(0.92)	(0.97)
Earnings Yield	(0.0142)	(0.0299)	(0.35)	(0.32)	(0.29)	(0.3)
Net Debt To E B I T D A	0.12	0.36	3.39	0.38	0.61	0.75
Current Ratio	1.02	2.21	46.42	14.94	10.93	10.82
Tangible Book Value Per Share	0.0494	0.14	8.2	6.34	3.18	2.42
Shareholders Equity Per Share	0.0529	0.14	(17.82)	(17.88)	(7.89)	(8.28)
Debt To Equity	0.16	0.0496	(0.002188)	(0.003999)	(0.002484)	(0.002359)
Capex Per Share	0.0293	0.0278	0.03	0.55	0.5	0.52
Graham Net Net	(0.0121)	0.0385	7.75	5.42	2.54	2.12
Interest Debt Per Share	0.008359	0.007153	0.0425	0.0717	0.0197	0.0216
Debt To Assets	0.0934	0.0331	0.004631	0.0105	0.005602	0.005322
Enterprise Value Over E B I T D A	(72.36)	(34.39)	0.46	(0.36)	(0.74)	(0.77)
Price Earnings Ratio	(70.49)	(33.48)	(2.85)	(3.1)	(3.48)	(3.66)
Price Book Value Ratio	191.15	68.59	(0.38)	(0.0996)	(0.21)	(0.2)
Price To Operating Cash Flows Ratio	(74.88)	(36.71)	(5.48)	(1.22)	(1.69)	(1.77)
Price To Free Cash Flows Ratio	(61.54)	(33.27)	(5.35)	(0.88)	(1.69)	(1.77)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:

How To Invest In ProKidney

Details

Is ProKidney Stock a good investment?

Details

What is ProKidney Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.62)

Revenue Per Share

0.001

Return On Assets

(0.26)

Return On Equity

(0.41)

The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ProKidney Historical Financial Ratios

About ProKidney Financial Ratios Analysis

ProKidney Corp Financial Ratios Chart

Price To Sales Ratio

Book Value Per Share

Ev To Sales

ProKidney Corp fundamentals Correlations

ProKidney Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ProKidney Corp fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

Days Sales Outstanding	+ 1.0	Price To Sales Ratio
Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Days Sales Outstanding
Cash Per Share	+ 1.0	Book Value Per Share
Pfcf Ratio	+ 1.0	Pocfratio

Income Quality	- 0.99	Cash Per Share
Capex To Operating Cash Flow	- 0.99	Capex To Depreciation
Income Quality	- 0.99	Book Value Per Share
Days Payables Outstanding	- 0.97	Payables Turnover
Roe	- 0.95	Operating Cash Flow Per Share
Pe Ratio	- 0.93	Pb Ratio